AVROBIO, Inc. (Nasdaq: AVRO) has made a significant announcement, revealing that it has entered into an agreement to sell its investigational hematopoietic stem cell (HSC) gene therapy program for the treatment of cystinosis to Novartis (NYSE: NVS). The deal entails a cash payment of $87.5 million.

Following this announcement, the pre-market trading of $AVRO is thriving at $1.40, experiencing a notable increase of $0.62 (+80.62%).

In other news, Compass Minerals International, Inc.? (NYSE: CMP) has signed a binding and multiyear supply agreement with Ford Motor Company (NYSE: F). The agreement ensures that Compass Minerals will provide battery-grade lithium carbonate from its lithium brine development project in Ogden, Utah. As per the terms, Compass Minerals will supply up to 40% of its planned phase-one battery-grade lithium carbonate to Ford for a duration of five years once production commences.

During pre-market, $CMP is trading at $34.39, showing a slight rise of $0.32 (+0.94%).

Shifting focus, Global-e Online Ltd. (Nasdaq: GLBE) has released its First Quarter 2023 financial report, revealing a loss of $0.26 per share. This outcome is more favorable than the consensus estimate loss of $0.29 per share.

However, $GLBE is currently trading at $33.00 in pre-market, experiencing a decline of $2.94 (-8.18%).

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY OR DIGITAL ASSET. Please consult with a professional investment advisor before purchasing or selling any securities viewed on or mentioned herein. (Read Full Disclaimer)